Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Oncology|September 15, 2022
Reprogramming lipid metabolism as potential strategy for hematological malignancy therapyLeqiang Zhang, Ning Chang, Jia Liu, et al.Materials Science & Engineering. C, Materials for Biological Applications|July 24, 2018
Electrospun PEGylated PLGA nanofibers for drug encapsulation and releaseLeqiang Zhang, Zhe Wang, Yunchao Xiao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T TherapyWei Chen, Hui Shi, Zhuojun Liu, et al.Cell Proliferation|July 10, 2026
iPSC-Derived iNK Progenitors Engraft and Generate NK Cells in Unconditioned and Autologous Immune Humanized MiceMin Zhang, Zhiqian Wang, Yanhong Liu, et al.Cell Proliferation|June 3, 2024
Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti-tumour activityYao Wang, Jianhuan Li, Zhiqian Wang, et al.Frontiers in Immunology|December 12, 2024
Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animalsQi Zhang, Chengxiang Xia, Qitong Weng, et al.Cell Stem Cell|February 26, 2026
Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia modelsZhiqian Wang, Leqiang Zhang, Dehao Huang, et al.Journal of Hematology & Oncology|May 19, 2025
Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignanciesYunqing Lin, Ziyun Xiao, Fangxiao Hu, et al.Journal for Immunotherapy of Cancer|September 8, 2025
CD33KO-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemiaYao Wang, Xiujuan Zheng, Zhiqian Wang, et al.Pageof 1